
Hims & Hers Health, Inc.: shareholders and insiders
Price
$16.51
November 19, 2026Market cap $3.7B
What Ploutos Investor adds for Hims & Hers Health
Part of Ploutos Investor, €9.99 a month
- The full history: 7 fiscal years, from 2019
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 26% since Nov 9, 2026, when the 10-Q these figures come from was filed ($22.94 then, $17.05 on Nov 18, 2026). The figures date from before that move.10-Q
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Nov 18, 2026, from their own Form 4 filings.
Bought on the market
$1.2M
1 person
Sold on the market
$19M
8 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan99%
- The rest1%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $1.2M by 1 person·sold $16M by 7 people
- 2025: no buys, sold $2.5M by 7 people
- 2026: bought $1.2M by 1 person, sold $16M by 7 people
- Nov 17, 2026Oluyemi OkupeChief Financial OfficerKind10b5-1
- Nov 17, 2026Deborah M. AutorChief Policy OfficerKind10b5-1
- Nov 17, 2026Soleil BoughtonChief Legal OfficerKind10b5-1
- Nov 13, 2026Christopher D PayneDirectorKind
- Nov 13, 2026Soleil BoughtonChief Legal OfficerKind
- Nov 13, 2026Soleil BoughtonChief Legal OfficerKind
- Nov 13, 2026Patrick Harrison CarrollChief Medical OfficerKind
- Nov 13, 2026Patrick Harrison CarrollChief Medical OfficerKind
- Nov 13, 2026Mohamed ElshenawyCTOKind
- Nov 13, 2026Mohamed ElshenawyCTOKind
- Nov 13, 2026Deborah M. AutorChief Policy OfficerKind
- Nov 13, 2026Deborah M. AutorChief Policy OfficerKind
- Nov 13, 2026Michael ChiChief Operating OfficerKind
- Nov 13, 2026Michael ChiChief Operating OfficerKind
- Nov 13, 2026Oluyemi OkupeChief Financial OfficerKind
- Nov 13, 2026Oluyemi OkupeChief Financial OfficerKind
- Nov 13, 2026David B WellsDirectorKind
- Nov 13, 2026Andrew DudumChief Executive OfficerKind
- Nov 13, 2026Andrew DudumChief Executive OfficerKind
- Oct 28, 2026Soleil BoughtonChief Legal OfficerKind10b5-1
- Oct 14, 2026Soleil BoughtonChief Legal OfficerKind10b5-1
- Oct 1, 2026Oluyemi OkupeChief Financial OfficerKind10b5-1
- Sep 30, 2026Soleil BoughtonChief Legal OfficerKind10b5-1
- Sep 22, 2026Oluyemi OkupeChief Financial OfficerKind10b5-1
- Sep 22, 2026Oluyemi OkupeChief Financial OfficerKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Oluyemi OkupeChief Financial Officer | 10b5-1 | 3,518 | $18.53 | $65.2K | Form 4 |
| Nov 17, 2026 | Deborah M. AutorChief Policy Officer | 10b5-1 | 23.8K | $18.53 | $441.5K | Form 4 |
| Nov 17, 2026 | Soleil BoughtonChief Legal Officer | 10b5-1 | 3,458 | $18.53 | $64.1K | Form 4 |
| Nov 13, 2026 | Christopher D PayneDirector | 810 | – | – | Form 4 | |
| Nov 13, 2026 | Soleil BoughtonChief Legal Officer | 42.3K | – | – | Form 4 | |
| Nov 13, 2026 | Soleil BoughtonChief Legal Officer | 21.5K | $19.73 | $424.2K | Form 4 | |
| Nov 13, 2026 | Patrick Harrison CarrollChief Medical Officer | 25.9K | – | – | Form 4 | |
| Nov 13, 2026 | Patrick Harrison CarrollChief Medical Officer | 10.2K | $19.73 | $201.2K | Form 4 | |
| Nov 13, 2026 | Mohamed ElshenawyCTO | 188.3K | – | – | Form 4 | |
| Nov 13, 2026 | Mohamed ElshenawyCTO | 95.8K | $19.73 | $1.9M | Form 4 | |
| Nov 13, 2026 | Deborah M. AutorChief Policy Officer | 40.0K | – | – | Form 4 | |
| Nov 13, 2026 | Deborah M. AutorChief Policy Officer | 16.1K | $19.73 | $318.6K | Form 4 | |
| Nov 13, 2026 | Michael ChiChief Operating Officer | 69.8K | – | – | Form 4 | |
| Nov 13, 2026 | Michael ChiChief Operating Officer | 38.6K | $19.73 | $761.2K | Form 4 | |
| Nov 13, 2026 | Oluyemi OkupeChief Financial Officer | 71.6K | – | – | Form 4 | |
| Nov 13, 2026 | Oluyemi OkupeChief Financial Officer | 36.4K | $19.73 | $718.9K | Form 4 | |
| Nov 13, 2026 | David B WellsDirector | 1,051 | – | – | Form 4 | |
| Nov 13, 2026 | Andrew DudumChief Executive Officer | 155.0K | – | – | Form 4 | |
| Nov 13, 2026 | Andrew DudumChief Executive Officer | 78.9K | $19.73 | $1.6M | Form 4 | |
| Oct 28, 2026 | Soleil BoughtonChief Legal Officer | 10b5-1 | 3,462 | $27.60 | $95.6K | Form 4 |
| Oct 14, 2026 | Soleil BoughtonChief Legal Officer | 10b5-1 | 3,461 | $29.06 | $100.6K | Form 4 |
| Oct 1, 2026 | Oluyemi OkupeChief Financial Officer | 10b5-1 | 2,000 | $29.70 | $59.4K | Form 4 |
| Sep 30, 2026 | Soleil BoughtonChief Legal Officer | 10b5-1 | 3,461 | $29.17 | $101.0K | Form 4 |
| Sep 22, 2026 | Oluyemi OkupeChief Financial Officer | 10b5-1 | 14.0K | $5.01 | $70.1K | Form 4 |
| Sep 22, 2026 | Oluyemi OkupeChief Financial Officer | 10b5-1 | 29.3K | $29.95 | $876.8K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by HIMS's officers and directors from 2021 up to November 18, 2025, 5 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- BlackRock, Inc.Class A StockShare of class11.9%
- Andrew DudumClass A common stock, $0.0001 par value per shareShare of class9.40%
- G1 Execution Services, LLCwith 3 more personsClass A Common Stock, $0.0001 par value per shareShare of class6.50%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc.Class A Stock | 11.9% | 26.50M | Jul 28, 20262 filings since Apr 17, 2025 | 13G/A | |
| Andrew DudumClass A common stock, $0.0001 par value per share | 9.40% | 22.61M | Aug 31, 20262 filings since Aug 13, 2025 | 13D/A | |
| G1 Execution Services, LLCwith 3 more personsClass A Common Stock, $0.0001 par value per share | 6.50% | 14.50M | May 15, 2026 | 13G |
Fell to 5% or less (4)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Bridgewater (Dalio)In the quarter×11.7
- Citadel Advisors (Griffin)In the quarter-43%
- Glenview CapitalIn the quarter
- Millennium Mgmt (Englander)In the quarter
- D.E. ShawIn the quarter-94%
- AQR CapitalIn the quarter-5.9%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Bridgewater (Dalio) | 82.3K | ×11.7 | $2.5M | 0.01% |
| Citadel Advisors (Griffin) | 480.0K | -43% | $14M | 0.01% |
| Glenview Capital | 19.8K | $600.0K | 0.01% | |
| Millennium Mgmt (Englander) | 132.9K | $4.0M | 0.00% | |
| D.E. Shaw | 10.0K | -94% | $300.0K | 0.00% |
| AQR Capital | 197.8K | -5.9% | $5.9M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 23.8% of its shares outstanding were held short, -2.4% since the report before.
- Shares held short
- 53.47M
- 23.8%
- Since the report before54.77M on Sep 30, 2026
- -2.4%
- 5.0
- 10.68M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 61%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 16.96M
- Nov 15, 2023: Shares held short 17.31M
- Nov 30, 2023: Shares held short 17.02M
- Dec 15, 2023: Shares held short 15.67M
- Dec 29, 2023: Shares held short 15.04M
- Jan 12, 2024: Shares held short 15.21M
- Jan 31, 2024: Shares held short 14.42M
- Feb 15, 2024: Shares held short 13.47M
- Feb 29, 2024: Shares held short 12.65M
- Mar 15, 2024: Shares held short 12.76M
- Mar 28, 2024: Shares held short 12.98M
- Apr 15, 2024: Shares held short 17.47M
- Apr 30, 2024: Shares held short 18.39M
- May 15, 2024: Shares held short 22.13M
- May 31, 2024: Shares held short 21.16M
- Jun 14, 2024: Shares held short 17.00M
- Jun 28, 2024: Shares held short 17.56M
- Jul 15, 2024: Shares held short 19.81M
- Jul 31, 2024: Shares held short 19.26M
- Aug 15, 2024: Shares held short 23.04M
- Aug 30, 2024: Shares held short 28.04M
- Sep 13, 2024: Shares held short 26.54M
- Sep 30, 2024: Shares held short 24.76M
- Oct 15, 2024: Shares held short 31.87M
- Oct 31, 2024: Shares held short 33.84M
- Nov 15, 2024: Shares held short 39.52M
- Nov 29, 2024: Shares held short 42.62M
- Dec 13, 2024: Shares held short 42.97M
- Dec 31, 2024: Shares held short 52.12M
- Jan 15, 2025: Shares held short 56.58M
- Jan 31, 2025: Shares held short 58.21M
- Feb 14, 2025: Shares held short 46.12M
- Feb 28, 2025: Shares held short 51.84M
- Mar 14, 2025: Shares held short 54.73M
- Mar 31, 2025: Shares held short 57.77M
- Apr 15, 2025: Shares held short 60.66M
- Apr 30, 2025: Shares held short 62.31M
- May 15, 2025: Shares held short 62.34M
- May 30, 2025: Shares held short 60.88M
- Jun 13, 2025: Shares held short 61.69M
- Jun 30, 2025: Shares held short 68.35M
- Jul 15, 2025: Shares held short 65.30M
- Jul 31, 2025: Shares held short 64.59M
- Aug 15, 2025: Shares held short 70.22M
- Aug 29, 2025: Shares held short 74.64M
- Sep 15, 2025: Shares held short 66.53M
- Sep 30, 2025: Shares held short 71.01M
- Oct 15, 2025: Shares held short 66.88M
- Oct 31, 2025: Shares held short 70.16M
- Nov 14, 2025: Shares held short 67.55M
- Nov 28, 2025: Shares held short 67.33M
- Dec 15, 2025: Shares held short 64.82M
- Dec 31, 2025: Shares held short 67.10M
- Jan 15, 2026: Shares held short 72.25M
- Jan 30, 2026: Shares held short 76.76M
- Feb 13, 2026: Shares held short 81.01M
- Feb 27, 2026: Shares held short 84.96M
- Mar 13, 2026: Shares held short 83.29M
- Mar 31, 2026: Shares held short 71.36M
- Apr 15, 2026: Shares held short 69.77M
- Apr 30, 2026: Shares held short 63.16M
- May 15, 2026: Shares held short 63.37M
- May 29, 2026: Shares held short 62.61M
- Jun 15, 2026: Shares held short 65.47M
- Jun 30, 2026: Shares held short 61.17M
- Jul 15, 2026: Shares held short 61.41M
- Jul 31, 2026: Shares held short 62.22M
- Aug 14, 2026: Shares held short 58.67M
- Aug 31, 2026: Shares held short 54.95M
- Sep 15, 2026: Shares held short 52.92M
- Sep 30, 2026: Shares held short 54.77M
- Oct 15, 2026: Shares held short 53.47M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading60.9% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 60.9% of the shares in the reported trades were short sales, against 60.7% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 60.9%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 60.7%
- Change
- +0.2 pts
- Short sales a dayon average, of 8.35M shares
- 5.08M
- More than atof 3,656 US-listed companies, same days
- 84%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 59.6%
- Oct 13, 2026: Short sales 58.3%
- Oct 14, 2026: Short sales 58.8%
- Oct 15, 2026: Short sales 61.8%
- Oct 16, 2026: Short sales 66.2%
- Oct 19, 2026: Short sales 62%
- Oct 20, 2026: Short sales 62.5%
- Oct 21, 2026: Short sales 59.9%
- Oct 22, 2026: Short sales 63%
- Oct 23, 2026: Short sales 66%
- Oct 26, 2026: Short sales 62.9%
- Oct 27, 2026: Short sales 52.1%
- Oct 28, 2026: Short sales 59.2%
- Oct 29, 2026: Short sales 56.8%
- Oct 30, 2026: Short sales 60.7%
- Nov 2, 2026: Short sales 52.2%
- Nov 3, 2026: Short sales 59.8%
- Nov 4, 2026: Short sales 52%
- Nov 5, 2026: Short sales 53.2%
- Nov 6, 2026: Short sales 59.1%
- Nov 9, 2026: Short sales 68.2%
- Nov 10, 2026: Short sales 62.3%
- Nov 11, 2026: Short sales 59.4%
- Nov 12, 2026: Short sales 65.4%
- Nov 13, 2026: Short sales 60.8%
- Nov 16, 2026: Short sales 58.3%
- Nov 17, 2026: Short sales 59.8%
- Nov 18, 2026: Short sales 59.2%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Andrew DudumChief Executive OfficerDirectly8.31M
- Michael ChiChief Operating OfficerDirectly487.8K
- Soleil BoughtonChief Legal OfficerDirectly311.2K
- Mohamed ElshenawyCTODirectly278.0K
- Oluyemi OkupeChief Financial OfficerDirectly274.0K
- David B WellsDirectorDirectly230.9K
- Patrick Harrison CarrollChief Medical OfficerDirectly213.6K
- Christopher D PayneDirectorDirectly145.7K
- Garcia Andrea G PerezDirectorDirectly83.8K
- Delos M. CosgroveDirectorDirectly68.0K
- Christiane PendarvisDirectorDirectly55.4K
- Deborah M. AutorChief Policy OfficerDirectly49.0K
- Anja ManuelDirectorDirectly38.7K
- Kare SchultzDirectorDirectly26.0K
- Irene BecklundPAODirectly14.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Andrew DudumChief Executive Officer | 8.31M | – | Nov 13, 2026 | Form 4 |
| Michael ChiChief Operating Officer | 487.8K | – | Nov 13, 2026 | Form 4 |
| Soleil BoughtonChief Legal Officer | 311.2K | – | Nov 17, 2026 | Form 4 |
| Mohamed ElshenawyCTO | 278.0K | – | Nov 13, 2026 | Form 4 |
| Oluyemi OkupeChief Financial Officer | 274.0K | – | Nov 17, 2026 | Form 4 |
| David B WellsDirector | 230.9K | – | Nov 13, 2026 | Form 4 |
| Patrick Harrison CarrollChief Medical Officer | 213.6K | – | Nov 13, 2026 | Form 4 |
| Christopher D PayneDirector | 145.7K | – | Nov 13, 2026 | Form 4 |
| Garcia Andrea G PerezDirector | 83.8K | – | Jun 11, 2026 | Form 4 |
| Delos M. CosgroveDirector | 68.0K | – | Jun 11, 2026 | Form 4 |
| Christiane PendarvisDirector | 55.4K | – | Jun 11, 2026 | Form 4 |
| Deborah M. AutorChief Policy Officer | 49.0K | – | Nov 17, 2026 | Form 4 |
| Anja ManuelDirector | 38.7K | – | Jun 15, 2026 | Form 4 |
| Kare SchultzDirector | 26.0K | – | Aug 14, 2026 | Form 4 |
| Irene BecklundPAO | 14.0K | – | Aug 14, 2026 | Form 4 |
A lower bound: it counts only the 15 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IHFiShares U.S. Healthcare Providers ETFWeight in the fund1.10%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.45%
- IJKiShares S&P Mid-Cap 400 Growth ETFWeight in the fund0.39%
- IWMiShares Russell 2000 ETFWeight in the fund0.23%
- VBKVanguard Small-Cap Growth Index FundWeight in the fund0.21%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.20%
- SPMDState Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETFWeight in the fund0.20%
- IJHiShares Core S&P Mid-Cap ETFWeight in the fund0.20%
- MDYState Street SPDR S&P MidCap 400SM ETF TrustWeight in the fund0.20%
- SCHASchwab U.S. Small-Cap ETFWeight in the fund0.13%
25 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 513
- Q4 2025: Managers 487
- Q1 2026: Managers 438
- Q2 2026: Managers 507
Institutional investors by quarter
The fund managers holding HIMS, quarter by quarter, from Q1 2020 to Q2 2025, 20 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 507 managers held 157M shares, worth $5.4B. During the quarter 143 opened a position, 74 closed one, 174 added and 127 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter+9.0%
- Vanguard Portfolio ManagementIn the quarter+3.7%
- Vanguard Capital ManagementIn the quarter+2.2%
- State StreetIn the quarter+9.2%
- Morgan StanleyIn the quarter-20%
- Divisadero Street Capital ManagementIn the quarter×12.8
- Geode Capital ManagementIn the quarter+9.3%
- Goldman Sachs GroupIn the quarter+111%
- JPMorgan ChaseIn the quarter-9.0%
- FMRIn the quarter×46.4
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 28.70M | +9.0% | $995M |
| Vanguard Portfolio Management | 10.56M | +3.7% | $366M |
| Vanguard Capital Management | 9.54M | +2.2% | $331M |
| State Street | 8.15M | +9.2% | $282M |
| Morgan Stanley | 7.15M | -20% | $248M |
| Divisadero Street Capital Management | 6.01M | ×12.8 | $208M |
| Geode Capital Management | 5.68M | +9.3% | $197M |
| Goldman Sachs Group | 5.17M | +111% | $179M |
| JPMorgan Chase | 4.77M | -9.0% | $159M |
| FMR | 4.32M | ×46.4 | $150M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Hims & Hers Health's filings show?
Who buys and sells is one part of Hims & Hers Health's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have HIMS's insiders bought or sold?
From May 26, 2026 to Nov 18, 2026 Hims & Hers Health's insiders bought $1.2M and sold $10M of shares on the market. 100% of the sales were under set 10b5-1 plans.
Which well-known managers hold HIMS?
6 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $14M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.